Therapeutic Effects of FGF23 c-tail Fc in a Murine Preclinical Model of X-Linked Hypophosphatemia Via the Selective Modulation of Phosphate ReabsorptionKristen Johnson(Pfizer (United States)), Jeanne Magram(Pfizer (United States))Journal of Bone and Mineral ResearchJune 10, 201710.1002/jbmr.3197Cited by 32SaveCiteExport RISWatch citationsRelated PapersIL-12 Receptor β2 (IL-12Rβ2)-Deficient Mice Are Defective in IL-12-Mediated Signaling Despite the Presence of High Affinity IL-12 Binding Sites|The Journal of Immunology|2000|160